For Research and Clinical Trials
Purified Amniotic Fluid
To help redefine the field of regenerative medicine through regenerative science and shape the future of this fledgling industry through meaningful partnerships and collaborations.LEARN MORE
Meet our Founders,
Chief Medical Officer
and our C-Level Team
NEOBIOSIS is a biotechnology company focused on the development and manufacturing of innovative perinatal products for research and clinical trials.Our goal is simple: to help redefine the field of regenerative medicine through regenerative science and shape the future of this fledgling industry though meaningful partnerships and collaborations. We are uniquely positioned to help usher in this new era of medicine, which focuses on the potential of perinatal birth tissues including cells, EVs and matrix.
Our philosophy is born out of early scientific experiments, a system referred to as heterochronic parabiosis (hetero-different, chronic-age, para-together, biosis-living). The idea is the body has all the tools necessary to repair and regenerate, and this ability is transferrable between individuals. This biological process was successfully demonstrated by transferring young tissues, cells and EVs to old laboratory subjects.LEARN MORE
NEOBIOSIS is a Contract Development & Manufacturing Organization (CDMO) with an operating research and development (R&D) program located at the University of Florida, Sid Martin Innovate Biotechnology Center — the #1 biotech incubator in the world– and two dedicated FDA-registered tissue processing cleanrooms, operated under current Good Manufacturing Practice (cGMP) standards, located in downtown Gainesville, Florida.